A Guide To Patient Engagement And Recruitment Solutions

Clinical trials have become significantly more complex over the past few decades, creating substantial barriers to effective patient recruitment. Increasingly stringent eligibility criteria, a growing number of trial endpoints, and heightened regulatory requirements all contribute to a shrinking pool of eligible participants and a more burdensome enrollment process. As a result, an estimated 86% of clinical trials fail to meet their original enrollment targets and timelines, while nearly one-third of Phase 3 trials are delayed or terminated due to insufficient patient recruitment.

The consequences of underenrollment extend far beyond operational setbacks. Delays in patient recruitment can postpone critical milestones, extend trial durations, and dramatically increase development costs. For drug developers, each day a trial is delayed can translate into losses of up to $8 million in potential revenue, underscoring the high financial stakes tied to timely enrollment.

This guide explores the most common challenges associated with clinical trial patient recruitment, including limited patient awareness, geographic and logistical barriers, and lack of engagement or trust. It also outlines practical strategies to overcome these obstacles through the use of modern patient engagement and recruitment solutions. By leveraging data-driven targeting, digital outreach, and patient-centric communication approaches, sponsors and research organizations can improve enrollment performance, accelerate timelines, and ultimately bring new therapies to market more efficiently.